Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19943077 | 0.95 | NPSR1 (0.32) | ALDH1A1HPGDNPSR1 | |
| SCHEMBL22563683 | 0.94 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDNPSR1ABCG2 | |
| SCHEMBL19909210 | 0.93 | METAP2 (0.33) | KDM4EALDH1A1HPGDPPARGSTAT3 | |
| SCHEMBL21278712 | 0.90 | ALDH1A1 (0.30) | KDM4EALDH1A1HPGDPPARGSTAT3 | |
| SCHEMBL19943081 | 0.89 | PDE9A (0.34) | KDM4EALDH1A1HPGDSTAT3NPSR1 | |
| SCHEMBL22563389 | 0.88 | ABCG2 (0.41) | KDM4EALDH1A1HPGDNPSR1ABCG2 | |
| SCHEMBL19942791 | 0.88 | L3MBTL1 (0.44) | KDM4EALDH1A1HPGDPPARGNPSR1 | |
| SCHEMBL23487305 | 0.88 | NPSR1 (0.37) | KDM4EALDH1A1HPGDPPARGSTAT3 | |
| SCHEMBL19942712 | 0.88 | NPSR1 (0.37) | KDM4EALDH1A1HPGDPPARGNPSR1 | |
| SCHEMBL19909215 | 0.88 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDNPSR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| EP-3580300-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | KDM4E 4619/4885ALDH1A1 80/4885HPGD 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.